申请人:Gist-Brocades N.V.
公开号:US04054595A1
公开(公告)日:1977-10-18
Novel 18 -, 19 - and 20 -hydroxy-prostaglandin derivatives of the formula I ##STR1## wherein the dotted line in the position 8-12 indicates the optional presence of a double bond, the waved lines in position 15 indicate that the hydroxyl group and the group R.sub.4 are either in .alpha.- or .beta.-position and Z represents a -- CH.sub.2 CH.sub.2 -- or a cis -- CH=CH -- group, and wherein R represents one of the groups: ##STR2## (wherein the waved lines indicate that the hydroxyl groups are either in .alpha.- or .beta.-position and R.sub.1 represents a hydrogen atom, a methyl or ethyl group), R.sub.2 represents either an oxygen atom or a hydrogen atom and an .alpha.- or .beta.-hydroxyl group, R.sub.3 represents a hydrogen atom or a hydroxyl group and R.sub.4 represents a hydrogen atom or a methyl group, with the proviso that when simultaneously, R.sub.1, R.sub.3 and R.sub.4 each represents a hydrogen atom, R.sub.2 represents an oxygen atom, a double bond is in 8-12 position and the 15-hydroxyl group is in position .alpha., R does not represent the group (b), but that when in addition to these conditions, Z represents a cis -- CH=CH -- group and the 8-12 position is saturated, R either represents the groups (b) or (c); and the pharmaceutically acceptable salts and esters thereof, novel process for their preparation by selective microbiological hydroxylation of compounds of formula II ##STR3## wherein the dotted line in the position 10-11 indicates the optional presence of a double bond in case the 8-12 position is saturated and the other symbols are as defined hereinabove, by means of microorganisms of the Division of Eumycota or, as far as the introduction of a hydroxyl group in the 18- or 19-position is concerned, of the Family of Streptomycetaceae, and, if desired, conversion of the 18 -, 19 - and 20 -hydroxy-prostaglandin derivatives thus obtained into pharmaceutically acceptable salts and esters thereof, and pharmaceutical compositions containing at least one of the novel hydroxy-prostaglandin derivatives of formula I.
18-, 19-和20-羟基前列腺素衍生物的化学式为I,其中8-12位置的虚线表示双键的可选存在,15位置的波浪线表示羟基和R.sub.4基团可以是α或β位,Z代表-CH.sub.2 CH.sub.2-或顺式-CH=CH-基团,而R代表以下一种基团:其中波浪线表示羟基可以是α或β位,R.sub.1代表氢原子、甲基或乙基基团,R.sub.2代表氧原子或氢原子和α或β-羟基基团,R.sub.3代表氢原子或羟基基团,R.sub.4代表氢原子或甲基基团,但是当同时R.sub.1、R.sub.3和R.sub.4各代表氢原子时,R.sub.2代表氧原子,8-12位置存在双键,15-羟基位于α位置时,R不代表(b)基团,但是当除此之外,Z代表顺式-CH=CH-基团且8-12位置饱和时,R代表基团(b)或(c);以及其药学上可接受的盐和酯,通过选择性微生物羟化化合物II的新过程制备,其中10-11位置的虚线表示8-12位置饱和时双键的可选存在,其他符号如上所定义,通过真菌门或者在引入18-或19-位置的羟基时,通过链霉菌科的微生物进行,如果需要,将得到的18-、19-和20-羟基前列腺素衍生物转化为药学上可接受的盐和酯,以及含有至少一种新的化学式I羟基前列腺素衍生物的药物组合物。